Thoratec Corp. recalls Thoratec HeartMate 3, LVAS Implant Kit, REF:106524INT, Sterile EO, RxOnly
- Recall date
- March 1, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1693-2024
- FDA classification
- Class I
- Brand / firm
- Thoratec Corp.
- Sold / distributed
- Worldwide Distribution: US (nationwide): AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, & WV; and OUS (foreign) countries of: Australia, Austria, Bangladesh, Belgium, Brazil, Bulgaria, C…
Why it was recalled
Potential for a leak path at the seal interface between the left ventricle assist system inflow cannula and the titanium apical cuff.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Thoratec HeartMate 3, LVAS Implant Kit, REF:106524INT, Sterile EO, RxOnly
Get recall alerts
Free email alert whenever Thoratec Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Thoratec Corp.